Cargando…

Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment

SIMPLE SUMMARY: Leukemia cutis occurs in different types of leukemia, most commonly in chronic lymphocytic leukemia and acute myeloid leukemia. Its varied clinical appearance makes it difficult to differentiate from other skin lesions. The leukemic skin changes are localized or disseminated and can...

Descripción completa

Detalles Bibliográficos
Autores principales: Robak, Ewa, Braun, Marcin, Robak, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670312/
https://www.ncbi.nlm.nih.gov/pubmed/38001655
http://dx.doi.org/10.3390/cancers15225393
_version_ 1785149300361134080
author Robak, Ewa
Braun, Marcin
Robak, Tadeusz
author_facet Robak, Ewa
Braun, Marcin
Robak, Tadeusz
author_sort Robak, Ewa
collection PubMed
description SIMPLE SUMMARY: Leukemia cutis occurs in different types of leukemia, most commonly in chronic lymphocytic leukemia and acute myeloid leukemia. Its varied clinical appearance makes it difficult to differentiate from other skin lesions. The leukemic skin changes are localized or disseminated and can be located in any site of the body. The diagnosis is mainly based on the clinical characteristics and histopathologic, as well as immunophenotypic features of the skin lesions. The treatment of leukemia cutis depends on the specific diagnosis of hematologic malignancy and is aimed at eradicating the primary underlying disease. Local irradiation for skin lesions is sometimes useful for palliative treatment. ABSTRACT: Leukemia cutis (LC) is defined as the leukemic infiltration of the epidermis, the dermis, and the subcutaneous tissue. Leukemia cutis may follow or occur simultaneously with the diagnosis of systemic leukemia. However, cutaneous lesions are occasionally diagnosed as the primary manifestation of leukemia. Leukemic skin infiltrations demonstrate considerable variation regarding a number of changes, distribution, and morphology. The highest incidence of LC is observed in chronic lymphocytic leukemia, monocytic and myelomonocytic acute myeloid leukemia, and T-cell lineage leukemia. Although the pathogenic mechanism of the invasion of leukemic cells into the skin is not well understood, chemokine receptors and adhesion molecules as well as the genetic characteristics of leukemia are thought to play a role. Leukemic skin lesions may be localized or disseminated and may occur alone or in combination on any site of the skin, most frequently in the trunk and extremities. The most common clinical presentations of leukemia cutis are papules, nodules, macules, plaques, and ulcers. In most patients, the complete or partial resolution of cutaneous infiltrations occurs simultaneously with hematologic remission. However, in patients with resistant disease or recurrent skin infiltration, local radiotherapy can be used. This review presents recent data on the pathogenesis, diagnosis, and treatment of leukemic skin involvement in different types of leukemia.
format Online
Article
Text
id pubmed-10670312
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-106703122023-11-13 Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment Robak, Ewa Braun, Marcin Robak, Tadeusz Cancers (Basel) Review SIMPLE SUMMARY: Leukemia cutis occurs in different types of leukemia, most commonly in chronic lymphocytic leukemia and acute myeloid leukemia. Its varied clinical appearance makes it difficult to differentiate from other skin lesions. The leukemic skin changes are localized or disseminated and can be located in any site of the body. The diagnosis is mainly based on the clinical characteristics and histopathologic, as well as immunophenotypic features of the skin lesions. The treatment of leukemia cutis depends on the specific diagnosis of hematologic malignancy and is aimed at eradicating the primary underlying disease. Local irradiation for skin lesions is sometimes useful for palliative treatment. ABSTRACT: Leukemia cutis (LC) is defined as the leukemic infiltration of the epidermis, the dermis, and the subcutaneous tissue. Leukemia cutis may follow or occur simultaneously with the diagnosis of systemic leukemia. However, cutaneous lesions are occasionally diagnosed as the primary manifestation of leukemia. Leukemic skin infiltrations demonstrate considerable variation regarding a number of changes, distribution, and morphology. The highest incidence of LC is observed in chronic lymphocytic leukemia, monocytic and myelomonocytic acute myeloid leukemia, and T-cell lineage leukemia. Although the pathogenic mechanism of the invasion of leukemic cells into the skin is not well understood, chemokine receptors and adhesion molecules as well as the genetic characteristics of leukemia are thought to play a role. Leukemic skin lesions may be localized or disseminated and may occur alone or in combination on any site of the skin, most frequently in the trunk and extremities. The most common clinical presentations of leukemia cutis are papules, nodules, macules, plaques, and ulcers. In most patients, the complete or partial resolution of cutaneous infiltrations occurs simultaneously with hematologic remission. However, in patients with resistant disease or recurrent skin infiltration, local radiotherapy can be used. This review presents recent data on the pathogenesis, diagnosis, and treatment of leukemic skin involvement in different types of leukemia. MDPI 2023-11-13 /pmc/articles/PMC10670312/ /pubmed/38001655 http://dx.doi.org/10.3390/cancers15225393 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Robak, Ewa
Braun, Marcin
Robak, Tadeusz
Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title_full Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title_fullStr Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title_full_unstemmed Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title_short Leukemia Cutis—The Current View on Pathogenesis, Diagnosis, and Treatment
title_sort leukemia cutis—the current view on pathogenesis, diagnosis, and treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670312/
https://www.ncbi.nlm.nih.gov/pubmed/38001655
http://dx.doi.org/10.3390/cancers15225393
work_keys_str_mv AT robakewa leukemiacutisthecurrentviewonpathogenesisdiagnosisandtreatment
AT braunmarcin leukemiacutisthecurrentviewonpathogenesisdiagnosisandtreatment
AT robaktadeusz leukemiacutisthecurrentviewonpathogenesisdiagnosisandtreatment